MedPath

Obesity-hypoventilation in Metabolic Syndrom Patients

Recruiting
Conditions
Metabolic Syndrome
Obesity Hypoventilation Syndrome
Capnography
Registration Number
NCT04839419
Lead Sponsor
SOS Oxygene Mediterranee
Brief Summary

The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.

Detailed Description

After being informed about the study and potential risks, patient agreed to participate and undergo :

a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled with a capnography during the same night.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • BMI>30 kg/m2
  • no treatment with CPAP nor NIV
Exclusion Criteria
  • obstructive respiratory disease
  • non-treated cardiac dysfunction

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Arterial pression in CO2At the inclusion

PaCO2

CapniaUp to one mont after inclusion

Arterial pression in CO2 and transcutaneous pression in CO2

Secondary Outcome Measures
NameTimeMethod
Arterial pression in oxygenAt the inclusion

PaO2

obstructive sleep apnea itemsUp to one mont after inclusion

Apnea-hypopnea index

HemoglobinAt the inclusion

Hb

somnolenceAt the inclusion

EPWORTH questionnaire; Minimum = 0; Maximum = 24, Higher score means a worth outcome

Physical activity levelAt the inclusion

Ricci\&Gagnon questionnaire, Minimum = 9; Maximum = 45, Higher score means a worth outcome

BMIAt the inclusion

body mass index

Arterial blood bicarbonatesAt the inclusion

HCO3-

Arterial blood gasesAt the inclusion

pH

Night Oxygen saturationUp to one mont after inclusion

SpO2

Trial Locations

Locations (1)

Clinique du Château de Vernhes

🇫🇷

Bondigoux, France

© Copyright 2025. All Rights Reserved by MedPath